SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060377
Filing Date
2023-11-07
Accepted
2023-11-07 16:57:41
Documents
80
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-20230930.htm   iXBRL 10-Q 2172450
2 EX-31.1 crbp-ex31_1.htm EX-31.1 18202
3 EX-31.2 crbp-ex31_2.htm EX-31.2 18372
4 EX-32.1 crbp-ex32_1.htm EX-32.1 10439
5 EX-32.2 crbp-ex32_2.htm EX-32.2 10325
  Complete submission text file 0000950170-23-060377.txt   10119899

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbp-20230930_def.xml EX-101.DEF 222716
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20230930.xsd EX-101.SCH 56858
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20230930_lab.xml EX-101.LAB 501480
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbp-20230930_cal.xml EX-101.CAL 58921
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20230930_pre.xml EX-101.PRE 408569
74 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20230930_htm.xml XML 2143837
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 231384884
SIC: 2834 Pharmaceutical Preparations